Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Functional roles of Akt signaling in mouse skin tumorigenesis

Abstract

The mouse skin carcinogenesis protocol is a unique model for understanding the molecular events leading to oncogenic transformation. Mutations in the Ha-ras gene, and the presence of functional cyclin D1 and the EGF receptor, have proven to be important in this system. However, the signal transduction pathways connecting these elements during mouse skin carcinogenesis are poorly understood. This paper studies the relevance of the Akt and ERK pathways in the different stages of chemically induced mouse skin tumors. Akt activity increases throughout the entire process, and its early activation is detected prior to increased cyclin D1 expression. ERK activity rises only during the later stages of malignant conversion. The observed early increase in Akt activity appears to be due to raised PI-3K activity. Other factors acting on Akt such as ILK activation and decreased PTEN phosphatase activity appear to be involved at the conversion stage. To further confirm the involvement of Akt in this process, PB keratinocytes were transfected with Akt and subsequently injected into nude mice. The expression of Akt accelerates tumorigenesis and contributes to increased malignancy of these keratinocytes as demonstrated by the rate of appearance, the growth and the histological characteristics of the tumors. Collectively, these data provide evidence that Akt activation is one of the key elements during the different steps of mouse skin tumorigenesis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG . 1995 J. Biol. Chem. 270: 23589–23597

  • Andjelkovic M, Alessi DR, Meier R, Fernandez A, Lamb NJC, Frech M, Cron P, Cohen P, Lucocq JM, Hemmings BA . 1997 J. Biol. Chem. 272: 31515–31524

  • Bianchi AB, Aldaz CM, Conti CJ . 1990 Proc. Natl. Acad. Sci. USA 87: 6902–6906

  • Burgering BM, Coffer PJ . 1995 Nature 376: 599–602

  • Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ . 1998 Oncogene 17: 1395–1413

  • Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA . 2000 Nat. Cell. Biol. 2: 76–83

  • Cantley LC, Neel BG . 1999 Proc. Natl. Acad. Sci. USA 96: 4240–4245

  • Cheng M, Sexl V, Sherr CJ, Roussel MF . 1998 Proc. Natl. Acad. Sci. USA 95: 1091–1096

  • Collado M, Medema RH, Garcia-Cao I, Dubuisson ML, Barradas M, Glassford J, Rivas C, Burgering BM, Serrano M, Lam EW . 2000 J. Biol. Chem. 275: 21960–21968

  • Conti CJ . 1994 Handbook of mouse mutations with skin and hair abnormalities Sundberg JP (ed) CRC Press, Inc., Boca Raton, Fla pp. 39–46

    Google Scholar 

  • Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS . 1995 Cell 81: 1137–1146

  • D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru KI, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'evm A, Troussard AA, Dedhar S, Pestell RG . 2000 J. Biol. Chem. 275: 32649–32657

  • Datta SR, Brunet A, Greenberg ME . 1999 Genes Dev. 13: 2905–2927

  • Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S . 1998 Proc. Natl. Acad. Sci. USA 95: 11211–11216

  • Díaz-Guerra M, Haddow S, Bauluz C, Jorcano JL, Cano A, Balmain A, Quintanilla M . 1992 Cancer Res. 52: 680–687

  • Di Cristofano A, Pandolfi PP . 2000 Cell 100: 387–390

  • Diehl JA, Cheng M, Roussel MF, Sherr CJ . 1998 Genes Dev. 12: 3499–3511

  • DiGiovanni J, Bol DK, Wilker E, Beltran L, Carbajal S, Moats S, Ramirez A, Jorcano J, Kiguchi K . 2000 Cancer Res. 60: 1561–1570

  • Dlugosz AA, Hansen L, Cheng C, Alexander N, Denning MF, Threadgill DW, Magnuson T, Coffey Jr RJ, Yuspa SH . 1997 Cancer Res. 57: 3180–3188

  • Furnari FB, Lin H, Huang HS, Cavenee WK . 1997 Proc. Natl. Acad. Sci. USA 94: 12479–12484

  • Furnari FB, Huang HJ, Cavenee WK . 1998 Cancer Res. 58: 5002–5008

  • Gille H, Downward J . 1999 J. Biol. Chem. 274: 22033–22040

  • Gimenez-Conti I, Aldaz CM, Bianchi AB, Roop DR, Slaga TJ, Conti CJ . 1990 Carcinogenesis 11: 1995–1999

  • Graff JR, Konicek BW, McNulty AM, Wang Z, Houck K, Allen S, Paul JD, Hbaiu A, Goode RG, Sandusky GE, Vessella RL, Neubauer BL . 2000 J. Biol. Chem. 275: 24500–24505

  • Gutkind JS, Lacal PM, Robbins KC . 1990 Mol. Cell. Biol. 10: 3806–3809

  • Hansen LA, Woodson 2nd RL, Holbus S, Strain K, Lo YC, Yuspa SH . 2000 Cancer Res. 60: 3328–3332

  • Harper JR, Reynolds SH, Greenhalgh DA, Strickland JE, Lacal JC, Yuspa SH . 1987 Carcinogenesis 8: 1821–1825

  • Larcher F, Bauluz C, Diaz-Guerra M, Quintanilla M, Conti CJ, Ballestin C, Jorcano JL . 1992 Mol. Carcinog. 6: 112–121

  • Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ, Pestell RG . 2000 Mol. Cell Biol. 20: 672–683

  • Leslie NR, Gray A, Pass I, Orchiston EA, Downes CP . 2000 Biochem. J. 346: 827–833

  • Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ, Yang-Yen HF . 1995 Mol. Cell Biol. 15: 3654–3663

  • Lu Y, Lin YZ, LaPushin R, Cuevas B, Fang X, Yu SX, Davies MA, Khan H, Furui T, Mao M, Zinner R, Hung MC, Steck P, Siminovitch K, Mills GB . 1999 Oncogene 18: 7034–7045

  • Meier R, Alessi DR, Cron P, Hemmings BA . 1997 J. Biol. Chem. 272: 30491–30497

  • Murga C, Fukuhara S, Gutkind JS . 2000 J. Biol. Chem. 275: 12069–12073

  • Murga C, Laguinge L, Wetzker R, Cuadrado A, Gutkind JS . 1998 J. Biol. Chem. 273: 19080–19085

  • Navarro P, Gomez M, Pizarro A, Gamallo C, Quintanilla M, Cano A . 1991 J. Cell Biol. 115: 517–533

  • Paramio JM, Casanova ML, Segrelles C, Mittnacht S, Lane EB, Jorcano JL . 1999b Mol. Cell. Biol. 19: 3086–3094

  • Paramio JM, Navarro M, Segrelles C, Gomez-Casero E, Jorcano JL . 1999a Oncogene 18: 7462–7468

  • Paramio JM, Segrelles C, Ruiz S, Jorcano JL . 2001 Mol. Cell. Biol. 21: 7449–7459

  • Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S . 2000 Proc. Natl. Acad. Sci. USA 97: 3207–3212

  • Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S . 2001 J. Biol. Chem. 276: 27462–27469

  • Quintanilla M, Brown K, Ramsden M, Balmain A . 1986 Nature 322: 78–80

  • Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH, Conti CJ . 1998 Genes Dev. 12: 2469–2474

  • Rodriguez-Puebla ML, LaCava M, Bolontrade MF, Russell J, Conti CJ . 1999a Mol. Carcinog. 26: 150–156

  • Rodriguez-Puebla ML, LaCava M, Conti CJ . 1999b Cell Growth Differ. 10: 467–472

  • Rodriguez-Puebla ML, LaCava M, Gimenez-Conti IB, Johnson DG, Conti CJ . 1998 Oncogene 17: 2251–2258

  • Rodriguez-Viciana P, Downward J . 2001 Methods Enzymol. 333: 37–44

  • Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD, Downward J . 1996 EMBO J. 15: 2442–2451

  • Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW . 1998 Cell 95: 29–39

  • Sibilia M, Fleischmann A, Behrens A, Stingl L, Carroll J, Watt FM, Schlessinger J, Wagner EF . 2000 Cell 102: 211–220

  • Simpson L, Parsons R . 2001 Exp. Cell. Res. 264: 29–41

  • Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S . 2001 Oncogene 20: 133–140

  • Tolkacheva T, Chan AM . 2000 Oncogene 19: 680–689

  • Vojtek AB, Der CJ . 1998 J. Biol. Chem. 273: 19925–19928

  • Weber JD, Hu W, Jefcoat Jr SC, Raben DM, Baldassare JJ . 1997 J. Biol. Chem. 272: 32966–32971

  • Wen S, Stolarov J, Myers P, Su DJ, Wigler MH, Tonks NK, Durden DL . 2001 Proc. Natl. Acad. Sci. USA 98: 4622–4627

  • Weng LP, Brown JL, Eng C . 2001 Hum. Mol. Genet. 10: 599–604

  • Xie W, Li F, Kudlow JE, Wu C . 1998 Am. J. Pathol. 153: 367–372

  • Yuspa SH . 1994 Cancer Res. 54: 1178–1189

  • Yuspa SH, Morgan D, Lichti U, Spangler EF, Michael D, Kilkenny A, Hennings H . 1986 Carcinogenesis 7: 949–958

  • Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC . 2001 Nat. Cell Biol. 3: 245–252

Download references

Acknowledgements

The authors are grateful to M Isabel de los Santos and Pilar Hernández for their excellent work in the histology core facility. This work was partially supported by grants PM98-0039 and SAF 98-0047 from the Spanish Ministry of Science and Technology, 1RO1CA79065-01, and CA79065-02 from NCI/NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jesús M Paramio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Segrelles, C., Ruiz, S., Perez, P. et al. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 21, 53–64 (2002). https://doi.org/10.1038/sj.onc.1205032

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205032

Keywords

This article is cited by

Search

Quick links